School of Medicine


Showing 4,681-4,700 of 4,710 Results

  • Niushen Zhang

    Niushen Zhang

    Clinical Associate Professor, Neurology & Neurological Sciences

    BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.

    Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.

  • Tian Yi Zhang, MD, PhD

    Tian Yi Zhang, MD, PhD

    Assistant Professor of Medicine (Hematology)

    BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.

    In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.

    Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).

    She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.

    Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.

    She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.

    Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies.

  • Renee Zhao

    Renee Zhao

    Assistant Professor of Mechanical Engineering and, by courtesy, of Materials Science and Engineering

    BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University where she directs the Soft Intelligent Materials Laboratory. Renee received her BS degree from Xi'an Jiaotong University in 2012, and her MS and PhD degrees from Brown University in 2014 and 2016, respectively. She was a postdoc associate at MIT during 2016-2018 prior to her appointment as an Assistant Professor in the Department of Mechanical and Aerospace Engineering at The Ohio State University from 2018 to 2021.

    Renee’s research focuses on the development of stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembling, sensing, and navigation. By combining mechanics, polymer engineering, and advanced material manufacturing techniques, the functional soft composites enable applications in soft robotics, miniaturized biomedical devices, flexible electronics, and deployable and morphing structures.

    Renee is a recipient of the ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF Career Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018).

  • Moss Zhao

    Moss Zhao

    Instructor, Neurosurgery

    BioDr. Moss Zhao is an Instructor at Department of Neurosurgery, Stanford University. He develops cutting-edge and clinically viable imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases across the lifespan. His specific areas of expertise include physiological modeling, arterial spin labeling, Bayesian inference, PET/MRI, and artificial intelligence. His scientific contributions could significantly improve the early detection of strokes and dementia as well as enrich the knowledge of brain development in the first two decades of life.

    Dr. Zhao received his DPhil at St Cross College of University of Oxford under the supervision of Prof. Michael Chappell. As an alumni mentor, he supports the career development of students of his alma mater. Since 2016, he has presented his work to more than 3000 delegates at international conferences and held leadership positions in professional societies. His research and teaching are supported by the American Heart Association, the National Institutes of Health, and the European Cooperation in Science and Technology.

  • Quan Zhou

    Quan Zhou

    Instructor, Neurosurgery

    Current Research and Scholarly InterestsCurrent Research Focus: molecular targeted theranostic imaging of brain tumor and enhanced drug delivery

    Areas of Insterests: molecular imaging, theranostics, fluorescence-guided surgery, brain tumor, drug delivery

    Dr. Zhou has made substantial contributions to the growing biomedical research field of Molecular Imaging. Molecular imaging emerged in the mid twentieth century as a highly specialized discipline at the intersection of molecular biology and in vivo imaging, focusing on imaging molecules of medical interest within intact living subjects. Dr. Zhou’s research addresses some of the nation’s most pressing issues related to the development of effective approaches for accurate detection of human diseases and improving their treatment outcome. Her innovations in molecular imaging technology enables the visualization, characterization, and quantification of biologic processes taking place at the cellular and subcellular levels. The multiple and numerous potentialities of Quan’s work are applicable to the diagnosis of diseases such as cancer, neurological and cardiovascular diseases. Her strong education background in biological sciences and biomedical engineering followed by postdoctoral training in translational and clinical research have helped her develop multiple disease-specific molecular probes and imaging strategies for early cancer diagnosis, image-guided surgery, therapeutic delivery prediction and at-risk cardiovascular plaque detection. Her research also contributes to improving the treatment of these disorders by testing and optimizing the execution of new interventions. Her work is expected to have a major economic impact due to earlier disease detection and personalized therapy.

    Dr. Zhou’s research has led to emergence of novel solutions and opportunities, in particular, for molecular imaging of cancer and other diseases, for discovering, leveraging and integration of cancer biomarker and tumor microenvironment information, and for novel approaches to acquire real-time high-resolution contrast enhanced visualization of tumor margin and optimization based on imaging depth, quality and speed. Dr. Zhou has been able to formulate the involved clinical and biological problems into biomedical engineering frameworks and find ways to exploit a variety of modern techniques and approaches from photoacoustic imaging, fluorescence-guided surgery, micro-electromechanical systems and therapeutic delivery strategies in developing elegant and effective solutions. Her work in the Neurosurgery Department and Molecular Imaging Program at Stanford involves research related to developing tumor-specific molecular probes, advanced imaging methods and therapeutic delivery systems for adult and pediatric patients with malignant brain cancers to improve margin detection, enhance resection accuracy, and improve treatment outcome.

  • Han Zhu

    Han Zhu

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.

  • Liangxue Zhu

    Liangxue Zhu

    Adjunct Clinical Instructor, Educational Programs and Services (EPS)

    BioDr. Liangxue (Julia) Zhu is board certified in Family Medicine and she joined Almaden Family Physicians Medical Group in 2009. She is an active-affiliate medical staff member at Good Samaritan Hospital.

    Dr. Zhu loves caring for her patients and is interested in all aspects of family medicine, especially women’s health and preventive medicine.

    In her spare time, Dr. Zhu enjoys hiking, jogging, cooking, and spending time with her two children.

  • Maisa Ziadni, PhD

    Maisa Ziadni, PhD

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsDevelopment and testing of novel interventions for chronic pain.
    Understanding mechanisms of treatment among patients with chronic with pain.
    Understanding predictors of opioid use among patients with chronic pain.